Pruritus impacts postoperative outcomes following skin cancer excision and linear repair

Read full text Summarise with VIRAT
Authors: Matthew Chen, Samantha S. Sattler, William Guo, Sandhya Ganesan, Maggie Weichert, James Briley, Daniel C. Butler
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Dear Editors, Persistent inflammatory conditions have been associated with impaired healing and increased infections.1, 2 The impact of pruritus on postoperative outcomes following skin cancer surgery remains poorly characterized.3 Herein, we investigate the effect of pruritus on rates of wound dehiscence and surgical site infection (SSI) following linear repairs of excised melanomas, squamous cell carcinomas (SCC), and basal cell carcinomas (BCC). A retrospective cohort study was conducted utilizing TrinetX database, a global health research network with aggregated data from over 275 million patients in 120 large healthcare organizations. Two distinct cohorts were examined: patients (ICD-10 L29) who underwent excision and linear repair for melanoma, SCC, or BCC after the pruritus diagnosis (cohort 1, n = 28,200) versus patients who underwent excision and linear repair for melanoma, SCC, or BCC without a pruritus diagnosis (cohort 2, n = 480,272). Only patients whose pruritus diagnosis preceded the excision encounter were included. Patients repaired with flaps, grafts, or secondary intention were excluded to control for inherently different postoperative outcomes with varying closure methods. Repair codes included intermediate and complex linear repairs, representing primary closures without flap or graft reconstruction. Propensity matching for demographic factors and smoking status was utilized to control for covariates (online supplementary Tables S1 and S2). Wound dehiscence (ICD T81.31XA) and post-repair SSI were analyzed for both cohorts. Patients with pruritus had higher overall rates of wound dehiscence (0.95%) and surgical site infection (2.23%) than patients without pruritus (0.30% and 0.63%, respectively; p < 0.001 for both outcomes). Among patients status post melanoma excision with linear repair, those with pruritus were more likely to experience wound dehiscence (odds ratio [OR], 1.487; 95% confidence interval [CI], 1.029–2.151; p = 0.034) (Figure 1) and surgical site infection (OR, 1.591; 95% CI, 1.222–2.07; p < 0.001) (Figure 2) compared with patients without pruritus. The odds ratio of wound dehiscence (OR, 1.663; 95% CI, 1.319–2.096; p < 0.001) (Figure 1) and surgical site infection (OR, 1.537; 95% CI, 1.294–1.825; p < 0.001) (Figure 2) was higher among patients with pruritus who underwent squamous cell carcinoma excision and linear repair. Regarding patients’ status following basal cell carcinoma excision and linear repair, those with pruritus had higher odds of wound dehiscence (OR, 1.729; 95% CI, 1.381–2.166; p < 0.001) (Figure 1) and surgical site infection (OR, 1.519; 95% CI, 1.287–1.793; p < 0.001) (Figure 2) compared with patients without pruritus. Pruritus is associated with increased postoperative complications following excision and linear repair of all analyzed skin cancer types. Increased scratching behavior, poor barrier recovery, abnormal microbiome colonization, or chronic inflammation may explain why patients with pruritus have consistently higher odds of wound dehiscence and SSI.4 Limitations to this study include the TrinetX database relying on ICD coding, which introduces the potential for misclassification and limits the ability to stratify pruritus by severity. Because the timing and etiology of pruritus could not be standardized, residual misclassification or inclusion of peri-operative irritation-related diagnoses are possible. Confounding could be present from propensity under-adjustment (not matching for obesity, vascular disease, renal disease, and immunosuppression). Post-repair SSI was not stratified by time, obscuring the distinction between early versus delayed infections. Furthermore, we did not account for individual patient treatments for pruritus, which may include topical steroids that potentially increase infection risk and delay wound healing, or other factors such as hygiene or dressing usage. Given an estimated lifetime prevalence of 22%, pruritus represents a common yet unnoticed risk factor for postoperative complications following skin cancer surgery.5 Recognition of pruritus as a possible contributor to delayed healing may inform future prospective studies aimed at optimizing perioperative management. None. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Fields of Study & Subjects

Nonmelanoma Skin Cancer Studies Wound Healing and Treatments Cutaneous Melanoma Detection and Management

Publication details

Journal / source
JDDG Journal der Deutschen Dermatologischen Gesellschaft
Volume
24
Issue
8
Pages
e1110–e1111
Publication date
19 March 2026
Language
DE